The gross proceeds to the Company from the registered direct offering are estimated to be approximately $12,000,000 before deducting the placement agent’s fees and other estimated offering expenses ...
Maxim Group assumed coverage on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Friday, Marketbeat reports. The firm issued a buy rating and a $10.00 price ...
Fintel reports that on March 21, 2025, Maxim Group initiated coverage of Anixa Biosciences (NasdaqCM:ANIX) with a Buy ...
Maxim Group analyst Anthony Vendetti maintained a Hold rating on Zivo Bioscience (ZIVO – Research Report) yesterday. The company’s shares ...
scPharmaceuticals (NASDAQ:SCPH – Get Free Report) had its target price dropped by investment analysts at Maxim Group from $20.00 to $12.00 in a report released on Thursday,Benzinga reports.
Fintel reports that on February 27, 2025, Maxim Group initiated coverage of STRATA Skin Sciences (NasdaqCM:SSKN) with a Buy recommendation. As of February 19, 2025, the average one-year price ...
Fintel reports that on March 21, 2025, Maxim Group initiated coverage of Anixa Biosciences (NasdaqCM:ANIX) with a Buy recommendation. As of March 19, 2025, the average one-year price target for ...